Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang, on behalf of The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol 2025;31(Suppl):S1-S31. Published online February 19, 2025
Metabolic dysfunction-associated steatotic liver disease and adverse pregnancy outcomes: a nationwide cohort study Young Mi Jung, Taesu Kim, Min-Jeong Oh, Dong Hyeon Lee, Geum Joon Cho, Won Kim Hepatology International.2026; 20(1): 69. CrossRef
Unmasking Kidney Risk in Steatotic Liver Disease: A Call for Metabolic Precision Chan-Young Jung Gut and Liver.2026; 20(1): 1. CrossRef
Prognostic value of non-invasive fibrosis assessment scores in predicting mortality among individuals with metabolic dysfunction-associated steatotic liver disease Lingjie Wu, Shunling Cai, Zhongbin Lin, Ruilie Chen, Yuanfeng Zhang, Xiaobing Gong BMC Public Health.2026;[Epub] CrossRef
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn Annals of Hepatology.2026; 31(2): 102199. CrossRef
Managing Metabolic Dysfunction–Associated Steatotic Liver Disease: Protocol for a Scoping Review of Patient Perceptions, Barriers, and Facilitators Sikyeong Park, Yu Shin Park, Dahye Hong, Bada Kang JMIR Research Protocols.2026; 15: e81404. CrossRef
Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm Chan‐Young Jung, Hye Won Lee, Jung Il Lee, Han Ah Lee, Seung Up Kim Diabetes, Obesity and Metabolism.2026; 28(6): 5240. CrossRef
Rethinking first-line screening in MASLD beyond the limitations of Fibrosis-4 index: Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease” Han Ah Lee, Young Youn Cho, Hyung Joon Kim Clinical and Molecular Hepatology.2026; 32(2): 921. CrossRef
Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach Beom Kyung Kim The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease: On track to become the dominant etiology of hepatocellular carcinoma: Reply to correspondence on “Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta- Jian Xu, Wei Zhang, Guo Wu, Jingdong Li Clinical and Molecular Hepatology.2026; 32(2): e257. CrossRef
Current Trends and Perspectives on Obesity and Metabolic Dysfunction-Associated Steatohepatitis in East Asia Soo Lim, Hui Zhou, Wataru Ogawa Journal of Obesity & Metabolic Syndrome.2026; 35(2): 130. CrossRef
Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond Walaa Abdelhamed, Mohamed Elbadry, Mohamed El-Kassas Liver Research.2026; 10(2): 109. CrossRef
Baduanjin for Non-Alcoholic Fatty Liver Disease: A Systematic Review Hyo-Ju Woo, Jung-Gyung Lee, Bong-Jin Shin, Jae-Jin Han, Sun-Young Park, Eui-Hyoung Hwang Journal of Korean Medicine Rehabilitation.2026; 36(2): 85. CrossRef
Surgically confirmed severe endometriosis is associated with lower risk of steatotic liver disease: Evidence of estrogen‐linked hepatic–reproductive crosstalk Jung Hyun Park, Keungmo Yang, Hyun Yang, Si Hyun Bae, Mee‐Ran Kim, Jaejun Lee International Journal of Gynecology & Obstetrics.2026;[Epub] CrossRef
Non-Invasive Tests in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Diagnosis to Treatment Monitoring Han Ah Lee, Young Youn Cho, Hyung Joon Kim Clinical Ultrasound.2026; 11(1): 1. CrossRef
An Arterial‐Enhancing Liver Nodule With Washout in a Patient With Metabolic and Alcohol‐Associated Liver Disease Soon Kyu Lee, Sun Young Jun, Young Chul Yoon Journal of Gastroenterology and Hepatology.2026; 41(7): 1991. CrossRef
Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol-related liver disease in human immunodeficiency virus Dinuka Bandara, Krishan Joshi, Carol Singh, Aalam Sohal, Mohanad Al-Qaisi, Nilofar Najafian World Journal of Virology.2026;[Epub] CrossRef
CT attenuation–based hepatic steatosis assessment using 3D organ segmentation: Impact of tube voltage and need for cutoff adjustment Jeongin Yoo, Ijin Joo, Sun Kyung Jeon, Junghoan Park, Jeong Min Lee European Journal of Radiology.2026; 203: 113021. CrossRef
Alcohol consumption and dementia risk in steatotic liver disease: a nationwide cohort study Ji Won Han, Seunghee Na, Kyungdo Han, Kyu Na Lee, Do Young Kim, Sang Hoon Ahn, Mi Na Kim Hepatology International.2026;[Epub] CrossRef
Pharmacological treatment of metabolic dysfunction–associated steatotic liver disease: a narrative review Jeong-Hwan Lee, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim Journal of the Korean Medical Association.2026; 69(6): 492. CrossRef
Uric Acid-to-HDL Cholesterol Ratio is Associated with Hepatic Steatosis but Not Fibrosis in Nonobese Adults: A NHANES 2017–2020 Study Linwan Li, Xiang’an Zhao Metabolic Syndrome and Related Disorders.2026; 24(8): 383. CrossRef
Efficacy of pharmacotherapies in improving liver fibrosis among patients with MASLD and fibrosis stages of F1-F3: systematic review and network meta-analysis Xin-Yue Sun, Hua-Ling Jiang, Yu-Tong Ma, Tian-Qi Xiong, Xie-Yuan Leng, Yi-Fan Zhao, Xian-Feng Shen, Chao Zhang, Yi-Jun Tang Journal of Translational Medicine.2026;[Epub] CrossRef
Steatotic liver disease subtypes and risk of hospitalization for sepsis: a nationwide cohort study Hye Seong, Se Yun Kim, Eun Hwa Lee, Dayeong Kim, Kyung Do Han, Sang Hoon Han Annals of Medicine.2026;[Epub] CrossRef
Emerging Indices Outperform Traditional Fibrosis Scores in Young Metabolic Dysfunction‐Associated Steatotic Liver Disease Across Divergent Screening Goals Ahlim Lee, Chang In Han, Keungmo Yang, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Jaejun Lee Journal of Gastroenterology and Hepatology.2026; 41(9): 2925. CrossRef
Steatotic Liver Disease Predicts Lower Likelihood of LDLR Gene Mutations in Young Korean Patients with Suspected Familial Hypercholesterolemia Chang In Han, Sung Hyun Cho, Keungmo Yang, Hyun Yang, Si Hyun Bae, Jaejun Lee Journal of Obesity & Metabolic Syndrome.2026; 35(3): 370. CrossRef
Correspondence to editorial 1 on “Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis” Moon Haeng Hur, Hyunjae Shin, Yoon Jun Kim Clinical and Molecular Hepatology.2026; 32(3): e378. CrossRef
Hepatic fibro-inflammation measured by magnetic resonance imaging iron-corrected T1 predicts extrahepatic cancer risk: a UK Biobank study Hye Yeon Chon, Seok-Jae Heo, SungA Bae, Tae Seop Lim, Ja Kyung Kim Clinical and Molecular Hepatology.2026; 32(3): 1349. CrossRef
The risk of cardiovascular events in metabolic dysfunction–associated steatotic liver disease according to fibrosis stage and diabetes status: A cohort study Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Jeong Eun Song, Hyun Chin Cho, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hye Won Lee, Seung Up Kim Hepatology Communications.2026;[Epub] CrossRef
Correspondence to editorial 2 on “Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis” Hyunjae Shin, Moon Haeng Hur, Yoon Jun Kim Clinical and Molecular Hepatology.2026; 32(3): e381. CrossRef
Risk of HCC in Elderly Patients With MASLD: Proposal of an Effective Surveillance Strategy Young Eun Chon, Kyung‐Do Han, Ju Dong Yang, Ju‐Yeong Park, Hyun‐Seok Kim, Hyung Woong Lee, Tae Seop Lim, Beom Kyung Kim Journal of Gastroenterology and Hepatology.2026; 41(9): 2913. CrossRef
Liver transplantation in patients with metabolic dysfunction-associated steatotic liver disease: a narrative review Suk Kyun Hong Journal of the Korean Medical Association.2026; 69(8): 631. CrossRef
Association Between Food Insecurity and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study in South Korea Seong-Uk Baek, Jin-Ha Yoon Nutrients.2026; 18(17): 2806. CrossRef
Guest editorial introduction to the special issue on “A Multidisciplinary Approach to Metabolic Dysfunction-Associated Steatotic Liver Disease: from Primary Care to Liver Transplantation” Won Kim Journal of the Korean Medical Association.2026; 69(8): 595. CrossRef
Bariatric surgery as a therapeutic strategy for metabolic dysfunction-associated steatotic liver disease in patients with obesity: a narrative review Yuri Cho Journal of the Korean Medical Association.2026; 69(8): 612. CrossRef
Primary care evaluation and fibrosis risk assessment of metabolic dysfunction-associated steatotic liver disease: a narrative review Hye Won Lee Journal of the Korean Medical Association.2026; 69(8): 598. CrossRef
Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: a narrative review of pathophysiology, diagnostic value, and therapeutic approaches Jung Woo Eun, Jae Youn Cheong, Soon Sun Kim Journal of the Korean Medical Association.2026; 69(8): 619. CrossRef
Dietary management of metabolic dysfunction-associated steatotic liver disease in the era of pharmacotherapy: a narrative review Joo Hyun Oh Journal of the Korean Medical Association.2026; 69(8): 603. CrossRef
Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma Eun Ji Jang, Ho Joong Choi, Young Kyoung You, Deok Hwa Seo, Mi Hyun Kwon, Keungmo Yang, Jaejun Lee, Jeong Won Jang, Seung Kew Yoon, Ji Won Han, Pil Soo Sung Cancers.2025; 17(9): 1548. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease, Recent Revision of Terminology and Its Implications Hyo Young Lee, Eileen L. Yoon The Korean Journal of Gastroenterology.2025; 85(2): 126. CrossRef
Advances in identifying risk factors of metabolic dysfunction-associated alcohol-related liver disease Rui-Qi Ye, Yi-Fan Chen, Chang Ma, Xi Cheng, Wei Guo, Sha Li Biomedicine & Pharmacotherapy.2025; 188: 118191. CrossRef
A Case Report of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with Improved Cardiometabolic Risk Factors Following Treatment with Saenggangunbi-tang Eun Kyung Lee, Min Jeong Park, Youngchul Kim, Jang-Hoon Lee The Journal of Internal Korean Medicine.2025; 46(2): 303. CrossRef
Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review Erdenetsogt Dungubat, Kohei Fujikura, Masahiko Kuroda, Toshio Fukusato, Yoshihisa Takahashi Nutrients.2025; 17(13): 2211. CrossRef
Associations between steatotic liver disease subtypes and incident atrial fibrillation in young adults: a nationwide cohort study Jeayeon Park, Goh Eun Chung, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Eun Ju Cho Cardiovascular Diabetology.2025;[Epub] CrossRef
Second-line antidiabetic drugs: friend or foe of the liver Jiwon Yang, Gunho Kim, Ju Hyun Shim, Jihyun An Journal of Liver Cancer.2025; 25(2): 187. CrossRef
Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease Anoushka Shenoy, Aijaz Ahmed, Donghee Kim Metabolism and Target Organ Damage.2025;[Epub] CrossRef
2025 Clinical Practice Guidelines for Diabetes: Management of Metabolic Dysfunction-Associated Steatotic Liver Disease Jaehyun Bae The Journal of Korean Diabetes.2025; 26(3): 172. CrossRef
Paired snRNA-seq and scRNA-seq analysis of MASLD patients to identify early-stage markers for disease progression Suebin Park, Su-Hyeon Lee, Se-eun Han, Beom Kyung Kim, Byungjin Hwang Hepatology Communications.2025;[Epub] CrossRef
Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease Ralf Weiskirchen, Amedeo Lonardo International Journal of Molecular Sciences.2025; 26(19): 9594. CrossRef
Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis Huiru Jin, Mengfan Jiao, Chengxiao Yu, Tingting Ren, Qingling Chen, Zixing Dai, Erfu Xie, Longfeng Jiang, Yuwen Li European Journal of Medical Research.2025;[Epub] CrossRef
Risk of Esophageal and Gastric Cancer by Histologic Subtype in Steatotic Liver Disease: A UK Biobank Study Donghoon Kang, Ji Won Han, Kenneth R. Muir, Artitaya Lophatananon, Jongin Lee Cancers.2025; 17(21): 3416. CrossRef
Implication of the Androgen Receptor in Muscle–Liver Crosstalk: An Overlooked Mechanistic Link in Lean-MASLD Eleni Myrto Trifylli, Christiana Charalambous, Nikolaos Spiliotopoulos, Nikolaos Papadopoulos, Anastasia Oikonomou, Spilios Manolakopoulos, Melanie Deutsch Livers.2025; 5(4): 65. CrossRef
Time-updated FIB-4 index predicts coronary artery calcification progression in individuals with metabolic dysfunction–associated steatotic liver disease Yesung Lee, Woncheol Lee Scientific Reports.2025;[Epub] CrossRef
Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim, on behalf of The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol 2024;30(Suppl):S5-S105. Published online August 19, 2024
Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis” Haiyu Wang, Jinjun Chen Clinical and Molecular Hepatology.2026; 32(1): e58. CrossRef
Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim Clinical Gastroenterology and Hepatology.2026; 24(7): 1897. CrossRef
Refining portal hypertension assessment: The clinical significance of spleen stiffness measurement in the Baveno VII Era: Editorial on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis” Do Seon Song Clinical and Molecular Hepatology.2026; 32(1): 400. CrossRef
Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement Joseph Rabbat, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel Tsochatzis, Salvatore Petta, Elisabetta Bugianesi, Masato Yoneda, Ming-Hua Zheng, Hannes Hagström, Jérôme Boursier, José Luis Calleja, George Boon-Bee Goh, Wah-Kheong Chan, Rocio Gallego-Durán, Clinical and Molecular Hepatology.2026; 32(1): 289. CrossRef
Non-invasive Risk-based Surveillance Strategy for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Ji Won Han The Korean Journal of Gastroenterology.2026; 86(1): 62. CrossRef
2025 KASL clinical practice guidelines for management of hepatitis C Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung Clinical and Molecular Hepatology.2026; 32(1): 1. CrossRef
Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease Subtypes Gi-Ae Kim, Heejoon Jang, Moon Young Kim, Jeong Hwan Park, Jung Gil Park, Eun-Young Cho, Jae Yoon Jeong, Seogsong Jeong, Seul Ki Han, Heesu Kwon, Youngae Jung, Geum-Sook Hwang, Yu Rim Lee, Soo Young Park, Sang Gyune Kim, Won Kim Gastroenterology.2026; 170(7): 1571. CrossRef
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patients Jaejun Lee, Dong Yeop Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Mi Young Byun, Seok Keun Cho, Seong Wook Yang, Si Hyun Bae, Pil Soo Sung Journal of Liver Cancer.2026; 26(1): 147. CrossRef
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn Annals of Hepatology.2026; 31(2): 102199. CrossRef
Diagnostic Value of MR Elastography and MRI‐Proton Density Fat Fraction in Cirrhosis Based on Explant Liver Histology Eun‐Ki Min, Seung‐seob Kim, Byungsoo Ahn, Deok‐Gie Kim, Dong Jin Joo, Sang Hoon Ahn, Seung Up Kim, Jae Geun Lee Journal of Gastroenterology and Hepatology.2026; 41(4): 1323. CrossRef
Systematic Review: Imaging‐Based Morphological Criteria for Liver Cirrhosis—A Call to Standardise Mei Chin Lim, Ethan Joo Wei Quek, Talia Yi Hui Chan, Margaret Teng, Cheng Han Ng, Mirudhula Gnanavelou, Vincent L. Chen, Jonathan A. Fallowfield, Huimiao Zhang, Mazen Noureddin, Donghyun Ko, Benjamin Nah, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Jimm Alimentary Pharmacology & Therapeutics.2026; 63(9): 1201. CrossRef
Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach Beom Kyung Kim The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef
The MASLD Journey in the General Population: Linkage‐to‐Care and Patient‐Reported Uptake of Fibrosis Risk Assessment Joo Hyun Oh, Jun‐Hyuk Lee, Sang Bong Ahn, Eunjoo Kwon, Eileen L. Yoon, Hyo Young Lee, Seon Cho, Dae Won Jun Liver International.2026;[Epub] CrossRef
Rethinking first-line screening in MASLD beyond the limitations of Fibrosis-4 index: Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease” Han Ah Lee, Young Youn Cho, Hyung Joon Kim Clinical and Molecular Hepatology.2026; 32(2): 921. CrossRef
AI Framework Integrated with InN Gas Sensing to Distinguish Sedentary Metabolic Fingerprints from Chronic Liver Disease Tsung Ming Chao, Rakesh Kumar Patnaik, Yu Chen Lin, Ming-Chih Ho, J. Andrew Yeh AI Sensors.2026; 2(2): 6. CrossRef
Risk Prediction of Early‐Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort Seogsong Jeong, Gi‐Ae Kim, Heejoon Jang, Dong Hyeon Lee, Sae Kyung Joo, Keon Wook Kang, Hwamin Lee, Won Kim Alimentary Pharmacology & Therapeutics.2026; 64(4): 507. CrossRef
Combined Associations of Lead and Arsenic Species with Liver Dysfunction and Hepatic Fibrosis Among Young Adults in Taiwan Kai-Wei Liao, Chih-Wen Wang, Wei-Lun Hung, Ya-Ling Chen, Yee-How Say, Yang-Ching Chen, Wei-Shan Chin Exposure and Health.2026;[Epub] CrossRef
Inflammatory activity stratification improves liver stiffness diagnosis of fibrosis in autoimmune hepatitis Yan Huang, Delin Liu, Yunjiang Li, Xu Zhang, Yu Tang Frontiers in Immunology.2026;[Epub] CrossRef
Non-Invasive Tests in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Diagnosis to Treatment Monitoring Han Ah Lee, Young Youn Cho, Hyung Joon Kim Clinical Ultrasound.2026; 11(1): 1. CrossRef
Alcohol consumption and dementia risk in steatotic liver disease: a nationwide cohort study Ji Won Han, Seunghee Na, Kyungdo Han, Kyu Na Lee, Do Young Kim, Sang Hoon Ahn, Mi Na Kim Hepatology International.2026;[Epub] CrossRef
Rule-Out Cutoff of Two-Dimensional Shear Wave Elastography for Significant Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease: Systematic Review, Meta-Analysis, and External Validation Joo Hyun Oh, Jonghyun Lee, Miyoung Choi, Kento Imajo, Masato Yoneda, Hideki Fujii, Hyo Young Lee, Eileen L. Yoon, Mimi Kim, Dae Won Jun Clinical Gastroenterology and Hepatology.2026; 24(9): 2387. CrossRef
Progression of Metabolic Dysfunction–Associated Steatohepatitis in US Adults Using Linked Records and Claims Yestle Kim, Romina Fakhraei, John C. O’Donnell, Karissa Johnston, Melissa Bather, Reem Mustafa, Andrew R. Kennedy, Amreen Dinani Gastro Hep Advances.2026; 5(9): 101031. CrossRef
Preventive strategies in hepatology: Role of multiparametric assessment of portal hypertension in chronic liver disease Angela Peltec, Ioan Sporea World Journal of Gastroenterology.2026;[Epub] CrossRef
Pharmabiotics, Phocaeicola dorei, ameliorates cholestatic liver fibrosis by alleviating macrophage efferocytosis of neutrophils Jung A Eom, In Gyu Park, Ji Ye Hyun, Na Young Lee, Goo Hyun Kwon, Sang Jun Yoon, Sung-Min Won, Young Lim Ham, Kyeong Jin Lee, Sang Hak Han, Dong-Hoon Yang, Dong Joon Kim, Ki Tae Suk Nature Communications.2026;[Epub] CrossRef
The risk of cardiovascular events in metabolic dysfunction–associated steatotic liver disease according to fibrosis stage and diabetes status: A cohort study Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Jeong Eun Song, Hyun Chin Cho, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hye Won Lee, Seung Up Kim Hepatology Communications.2026;[Epub] CrossRef
Threshold‐Defined Liver Stiffness Trajectories and Liver‐Related Event Risk in Chronic Liver Disease: A Cohort Study Dong Yun Kim, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Liver International.2026;[Epub] CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA) Won-Mook Choi, Ji Won Han, Tae Hyung Kim, Miyoung Choi, Moon Haeng Hur, Hyo Young Lee, Han Ah Lee, Byeong Geun Song, Heechul Nam, Jeong-Ju Yoo, Chang Hun Lee, Gi-Ae Kim, Hye Won Lee, Gwang Hyeon Choi, Young Eun Chon, Yun Bin Lee, Dong Hyun Sinn, Bo Hyun K Clinical and Molecular Hepatology.2026; 32(3): 1029. CrossRef
Shear Wave Elastography Combined with ALBI Score Enhances Prediction of Hepatic Decompensation in Chronic Liver Disease Jaejun Lee, Hyun Yang, Si Hyun Bae, Sun Hong Yoo, Soon Woo Nam, Jiwoon Yoon, Jung Hyun Kwon, Soon Kyu Lee JHEP Reports.2026; : 101963. CrossRef
Emerging Indices Outperform Traditional Fibrosis Scores in Young Metabolic Dysfunction‐Associated Steatotic Liver Disease Across Divergent Screening Goals Ahlim Lee, Chang In Han, Keungmo Yang, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Jaejun Lee Journal of Gastroenterology and Hepatology.2026; 41(9): 2925. CrossRef
Primary care evaluation and fibrosis risk assessment of metabolic dysfunction-associated steatotic liver disease: a narrative review Hye Won Lee Journal of the Korean Medical Association.2026; 69(8): 598. CrossRef
Comparable Predictive Performance of Non‐VCTE–Based Machine Learning Model for HBV‐Infected Hepatocellular Carcinoma Risk Hahn Yi, Hye Won Lee, Jae Il Shin, Hyung Woong Lee, Tae Seop Lim, Beom Kyung Kim, Namkug Kim Journal of Gastroenterology and Hepatology.2026;[Epub] CrossRef
Leveraging serum CHI3L1 and machine learning for non-invasive liver fibrosis diagnostics Haizhen Chen, Gaixia Zhang, Yingwen Zhang, Li Li, Yuanyuan Che, Jing Huang iScience.2026; 29(9): 117372. CrossRef
LAD-NASH score using multiparametric ultrasound for identification of at-risk MASH: head-to-head comparison with the FAST score Seung-seob Kim, Jae Seung Lee, Min Young Lee, Sunyoung Lee Ultrasonography.2026; 45(5): 439. CrossRef
Association of noninvasive liver fibrosis scores with severity and outcomes among individuals with cardiovascular-kidney-metabolic syndrome: evidence from the NHANES 2005–2018 Yue Gao, Huiwen Chen, Jiawen Li, Mengli Chen, Haifeng Zhang BMC Cardiovascular Disorders.2026;[Epub] CrossRef
Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4–based two-step algorithms for MASLD Jaejun Lee, Hyun Yang, Si Hyun Bae, Sunhong Yoo, Soon Woo Nam, Jiwoon Yoon, Jung Hyun Kwon, Soon Kyu Lee Hepatology.2026;[Epub] CrossRef
Associations of antihypertensive medication class with liver fibrosis and mortality in US adults with MASLD Yu Wu, Fei Fang Clinical and Experimental Hypertension.2026;[Epub] CrossRef
Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis” Hee Yeon Kim, Miyoung Choi, Dae Won Jun Clinical and Molecular Hepatology.2025; 31(1): e48. CrossRef
Non-Invasive Liver Fibrosis Test Using Shear Wave Elastography Ji Won Han The Korean Journal of Medicine.2025; 100(1): 26. CrossRef
Influence of Sex in the Development of Liver Diseases Jie-Wen Zhang, Nan Zhang, Yi Lyu, Xu-Feng Zhang Seminars in Liver Disease.2025; 45(01): 015. CrossRef
KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025 Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang Clinical and Molecular Hepatology.2025; 31(Suppl): S1. CrossRef
Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study G. Craig Wood, Anthony Hoovler, Rakesh Luthra, Christopher D. Still, Hamzah Shariff, Matthew Still, Jonathan Hayes, Peter Benotti, Chioma Uzoigwe Expert Review of Gastroenterology & Hepatology.2025; 19(4): 427. CrossRef
Age serves as the silent architect of FIB-4’s precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on “Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liv Ji Won Han, Dae Won Jun Clinical and Molecular Hepatology.2025; 31(2): e152. CrossRef
The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study Yanjun Guo, Wei Su, Lulong Tao, Guoxin Zhang, Kun Wang BMC Gastroenterology.2025;[Epub] CrossRef
Future Perspectives of Liver Research in the Asia‐Pacific Region: Focus on Hepatitis B and C Beom Kyung Kim Journal of Gastroenterology and Hepatology.2025; 40(8): 1855. CrossRef
Novel Insights into Noninvasive Assessment of Liver Fibrosis in Chronic Hepatitis C Patients Guanlan Liu, Li Liu, Xing Yang, Qihao Wang, Mingqin Qian Journal of Clinical and Experimental Hepatology.2025; 15(6): 102610. CrossRef
A Case Report of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with Improved Cardiometabolic Risk Factors Following Treatment with Saenggangunbi-tang Eun Kyung Lee, Min Jeong Park, Youngchul Kim, Jang-Hoon Lee The Journal of Internal Korean Medicine.2025; 46(2): 303. CrossRef
Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Clinical and Molecular Hepatology.2025; 31(3): 1018. CrossRef
Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population Jean-Bonny Nsumbu, Jean-Robert Makulo, Trésor Mutombo Tshiswaka, Christian Kisoka Lusunsi, Charles Nlombi Mbendi Hepatic Medicine: Evidence and Research.2025; Volume 17: 27. CrossRef
Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis Toshikazu Kohira, Satoshi Oeda, Erina Eto, Yoshihito Kubotsu, Misa Norita, Kaori Inoue, Nagisa Hara, Shotaro Noge, Kenichi Tanaka, Shigenobu Yoshimura, Noriko Oza, Keizo Anzai, Yuichiro Eguchi, Cheng Han Ng, Daniel Q. Huang, Mark D. Muthiah, Atsushi Kawag Scientific Reports.2025;[Epub] CrossRef
Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study Jung Hee Kim, Jae Hyun Yoon, Sung-Eun Kim, Ji-Won Park, Yewan Park, Gi-Ae Kim, Seong Kyun Na, Young-Sun Lee, Jeong Han Kim Medicina.2025; 61(9): 1601. CrossRef
Comment on ‘Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank’ by T. S. Lim et al.—Authors' Reply Tae Seop Lim, Sujin Kwon, Sung A Bae, Hye Yeon Chon, Seol A. Jang, Ja Kyung Kim, Chul Sik Kim, Seok Won Park, Kyoung Min Kim Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn Journal of Gastroenterology and Hepatology.2025; 40(11): 2750. CrossRef
Prospects of late-stage development agents in the treatment of metabolic dysfunction-associated steatohepatitis Brian Lee, Ussama Ghumman, Lisa D. Pedicone, Andres Gomez Aldana, Eric Lawitz Clinical and Molecular Hepatology.2025; 31(4): 1167. CrossRef
Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis Huiru Jin, Mengfan Jiao, Chengxiao Yu, Tingting Ren, Qingling Chen, Zixing Dai, Erfu Xie, Longfeng Jiang, Yuwen Li European Journal of Medical Research.2025;[Epub] CrossRef
Mistakes in the utilization of vibration-controlled transient elastography in the evaluation of liver fibrosis: a narrative review Madunil Anuk Niriella, Uditha Bandara Dassanayake, Charith Priyanga Madurapperuma, Indeewari Prathibha Wijesingha, Arjuna Priyadarshin De Silva, Hithnadura Janaka de Silva Expert Review of Gastroenterology & Hepatology.2025; 19(12): 1299. CrossRef
A Novel Deep Learning Framework for Liver Fibrosis Staging and Etiology Diagnosis Using Integrated Liver–Spleen Elastography Kai Yang, Fei Chen, Aiping Tian, Long Deng, Xiaorong Mao Diagnostics.2025; 15(23): 2986. CrossRef
Shear-Wave Elastography: Principles, Techniques, and Clinical Considerations Jae Seung Lee Clinical Ultrasound.2025; 10(2): 53. CrossRef
Vibration-Controlled Transient Elastography in Chronic Liver Disease: Current Research Insights Ho Soo Chun Clinical Ultrasound.2025; 10(2): 69. CrossRef
Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease Jung Hwan Yu The Korean Journal of Medicine.2024; 99(5): 232. CrossRef
Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography Mi Na Kim The Korean Journal of Gastroenterology.2024; 84(5): 201. CrossRef
Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B Ye Ji Jun, Minjong Lee, Ho Soo Chun, Tae Hun Kim The Korean Journal of Gastroenterology.2024; 84(5): 206. CrossRef
Serological Markers to Assess Liver Fibrosis and Their Roles Beom Kyung Kim The Korean Journal of Gastroenterology.2024; 84(5): 195. CrossRef
Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography Han Ah Lee Clinical Ultrasound.2024; 9(2): 70. CrossRef
First
Prev
